Literature DB >> 22397204

Impact of second reminder invitation on uptake of screening and cancer detection in BreastCheck.

P Fleming1, T Mooney, P Fitzpatrick.   

Abstract

This research aims to quantify the impact of reminder invitations on uptake and cancer detection in Ireland. Examination of BreastCheck's clinical database (2000-2010) to determine number of women screened following first invitation and after reminder; comparison by age group and screening phase with outcomes of recall rate, cancer detection and true positive rates. Of 819,182 first invitations sent 448,974 (54.8%) women attended. 245,157 (66.2%) women attended after reminder invitations, increasing uptake by 29.9% to 694,131 (84.7%) and cancers detected by 1,550 (35%). Women awaiting a reminder were less likely recalled for assessment 9,555 (3.9%) than respondents to first invitation 2,887 (4.04%) (p=0.004). Younger, mainly initial women were more likely recalled for assessment after first invitation. There was no difference between cohorts for cancer detection rate or true positive rate. Reminders increased uptake, supporting international evidence. For programme efficiency attendance at first invitation is optimal. For maximum programme effectiveness attendance must be encouraged with reminders.

Entities:  

Mesh:

Year:  2012        PMID: 22397204

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  2 in total

1.  A randomised trial of the effect of postal reminders on attendance for breast screening.

Authors:  Prue C Allgood; Anthony J Maxwell; Sue Hudson; Judith Offman; Gillian Hutchison; Cathryn Beattie; Raquel Tuano-Donnelly; Anthony Threlfall; Tina Summersgill; Lesley Bellis; Collette Robinson; Samantha Heaton; Julietta Patnick; Stephen W Duffy
Journal:  Br J Cancer       Date:  2016-01-19       Impact factor: 7.640

2.  Rapid review of evaluation of interventions to improve participation in cancer screening services.

Authors:  Stephen W Duffy; Jonathan P Myles; Roberta Maroni; Abeera Mohammad
Journal:  J Med Screen       Date:  2016-10-17       Impact factor: 2.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.